Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03598829 · ClinicalTrials.gov registry record
A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 219
- Enrollment target
NCT03598829: Completed study, sponsored by Mayo Clinic.
NCT03598829 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 219 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03598829 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 219 participants
- Enrollment target
Study Summary
This research is being done to see if the amount of an enzyme in blood (called serum mast cell tryptase) changes before and after surgery. The investigators would like to see if these amounts are related to knee stiffness and pain in subjects that undergo a total knee replacement.
Primary Outcome
Serum mast tryptase values will be assessed pre and postoperatively to evaluate changes that can be expected in patients who are undergoing total knee replacement.
Interventions
- DIAGNOSTIC_TEST Tryptase, Serum test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2023-11-15 |
What the finished NCT03598829 record still lists
NCT03598829 is an observational study that tracks outcomes without assigning an intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Tryptase, Serum test is the first listed.
NCT03598829 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03598829 about?
NCT03598829 is a clinical study titled "A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients". This research is being done to see if the amount of an enzyme in blood (called serum mast cell tryptase) changes before and after surgery. The investigators would like to see if these amounts are related to knee stiffness and pain in subjects that undergo a total knee replacement.
What is the current status of trial NCT03598829?
This trial is currently completed. The enrollment target is 219 participants. The study started on 2018-07-01. Estimated completion is 2023-11-15.
What interventions are being tested in trial NCT03598829?
The interventions under investigation include: Tryptase, Serum test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03598829?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI